Patient and Public Involvement in Health Economics Modelling Raises the Need for Normative Guidance

被引：0
作者：
Stephanie Harvard
Eric Winsberg
机构：
[1] University of British Columbia (UBC),Faculty of Pharmaceutical Sciences
[2] University of Cambridge,Department of History and Philosophy of Science
[3] University of South Florida,Department of Philosophy
来源：
PharmacoEconomics | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Patient and public involvement in health economics research and health technology assessment has been increasing for some time; however, patient and public involvement in health economics modelling is a more recent development. One reason to advance this type of involvement is to help appropriately manage the social and ethical value judgements that are required throughout model development and interpretation. At the same time, patient and public involvement in health economics modelling raises numerous practical and philosophical issues that invite discussion and debate. Recently, we attended an engagement event which invited patients, members of the public, researchers and decision-makers to discuss some of these issues. One priority that emerged in the discussion was to develop normative guidance for patient and public involvement in health economics modelling. In this article, we reflect on this goal from our own perspective, focusing on why normative guidance is needed and what questions that guidance should answer.
引用
收藏
页码：733 / 740
页数：7
相关论文
共 160 条
  • [1] Husereau D(2022)Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations Pharmacoeconomics 40 601-609
  • [2] Drummond M(2019)Working with patients and members of the public: informing health economics in child health research PharmacoEconomics Open 3 133-141
  • [3] Augustovski F(2018)Involving members of the public in health economics research: insights from selecting health states for valuation to estimate quality-adjusted life-year (QALY) weights Appl Health Econ Health Policy 16 187-194
  • [4] Bekker-Grob E(2021)Patient and public involvement (PPI) in health economics methodology research: reflections and recommendations Patient 14 421-427
  • [5] Briggs AH(2021)Designing discrete choice experiments using a patient-oriented approach Patient 14 389-397
  • [6] Carswell C(2021)Patients and public are important stakeholders in health technology assessment but the level of involvement is low—a call to action. Research involvement and engagement BioMed Central 7 1-11
  • [7] Kandiyali R(2016)Patients’ perspectives can be integrated in health technology assessments: an exploratory analysis of CADTH Common Drug Review Res Involv Engage 2 1-13
  • [8] Hawton A(2019)Stories of patient involvement impact in health technology assessments: a discussion paper Int J Technol Assess Health Care 35 266-272
  • [9] Cabral C(2021)Developing a framework for public involvement in mathematical and economic modelling: bringing new dynamism to vaccination policy recommendations Patient 14 435-445
  • [10] Mytton J(2021)Putting stakeholder engagement at the center of health economic modeling for health technology assessment in the United States Pharmacoeconomics 39 631-638
12345678910